ARTICLE | Company News
Myriad Genetics, Saladax sales and marketing update
February 18, 2013 8:00 AM UTC
Saladax said Myriad will return North American rights to its My5-FU diagnostic test following a pipeline evaluation. Saladax said Myriad, which had marketed the test as OnDose, will return rights wh...